HR 1730
116th Congress
House
Health
Cancer
Drug therapy
Health care costs and insurance
Health care coverage and access
Prescription drugs
Cancer Drug Parity Act of 2019
Introduced: March 13, 2019
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 14, 2019
Referred to the Subcommittee on Health.
Mar 13, 2019
Referred to the House Committee on Energy and Commerce.
Mar 13, 2019
Introduced in House
Plain-English summary
Cancer Drug Parity Act of 2019
This bill requires health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration.
To comply with this requirement, health plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2